A detailed history of Fmr LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 70,476 shares of RLAY stock, worth $534,208. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70,476
Previous 1,086,089 93.51%
Holding current value
$534,208
Previous $9.01 Million 94.91%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$5.9 - $8.02 $5.99 Million - $8.15 Million
-1,015,613 Reduced 93.51%
70,476 $459,000
Q1 2024

May 13, 2024

SELL
$7.5 - $12.07 $2.77 Million - $4.45 Million
-368,854 Reduced 25.35%
1,086,089 $9.01 Million
Q4 2023

Feb 13, 2024

SELL
$6.01 - $11.48 $3.92 Million - $7.49 Million
-652,790 Reduced 30.97%
1,454,943 $16 Million
Q3 2023

Nov 13, 2023

SELL
$8.24 - $12.97 $6.99 Million - $11 Million
-848,488 Reduced 28.7%
2,107,733 $17.7 Million
Q2 2023

Aug 11, 2023

SELL
$9.99 - $18.27 $58.4 Million - $107 Million
-5,850,770 Reduced 66.43%
2,956,221 $37.1 Million
Q1 2023

May 11, 2023

SELL
$15.0 - $22.76 $13.9 Million - $21.1 Million
-926,857 Reduced 9.52%
8,806,991 $145 Million
Q4 2022

Feb 13, 2023

SELL
$14.16 - $24.02 $31.5 Million - $53.4 Million
-2,224,364 Reduced 18.6%
9,733,848 $145 Million
Q3 2022

Nov 10, 2022

SELL
$18.07 - $31.37 $24.9 Million - $43.2 Million
-1,376,843 Reduced 10.32%
11,958,212 $268 Million
Q2 2022

Aug 12, 2022

SELL
$13.31 - $34.88 $38.7 Million - $101 Million
-2,906,951 Reduced 17.9%
13,335,055 $223 Million
Q1 2022

May 13, 2022

BUY
$20.26 - $32.36 $717,305 - $1.15 Million
35,405 Added 0.22%
16,242,006 $486 Million
Q4 2021

Feb 14, 2022

BUY
$26.0 - $37.03 $65.5 Million - $93.3 Million
2,519,797 Added 18.41%
16,206,601 $498 Million
Q3 2021

Nov 15, 2021

BUY
$29.75 - $37.99 $98.9 Million - $126 Million
3,324,804 Added 32.09%
13,686,804 $432 Million
Q2 2021

Aug 13, 2021

BUY
$27.5 - $38.19 $285 Million - $396 Million
10,362,000 New
10,362,000 $379 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $911M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.